VANCOUVER, B.C. – Acuitas Therapeutics is proud to announce a multi-year sponsorship agreement with Vancouver Athletic Football Club (VAFC). This sponsorship will allow the club to expand their training resources… Read More
PARIS – Pfizer (PFE.N) will add a production facility for its antiviral COVID-19 pill in France as part of a plan to invest 520 million euros ($594 million) in the country… Read More
PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets) is authorized for use in high-risk adults (18 years of age and older) Pfizer is ready to start immediate delivery in Canada, in accordance… Read More
Lithuania’s life sciences sector has been rising to prominence internationally for the past decade. Boosted by world-leading biotechnology research and strong educational institutions that supply businesses with top-notch talent, the… Read More
VANCOUVER, BC – Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, is pleased to announce an extension of the option agreement with an undisclosed publicly traded South Korean biopharmaceutical company,… Read More
